Cargando…
2019 Chinese expert consensus statement on aspirin application in primary prevention of cardiovascular disease
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249706/ https://www.ncbi.nlm.nih.gov/pubmed/32433054 http://dx.doi.org/10.1097/CM9.0000000000000762 |
| _version_ | 1783538640629006336 |
|---|---|
| author | Li, Xiao-Ying Shi, Zhong-Wei Zhao, Dong Yin, Da-Wei |
| author_facet | Li, Xiao-Ying Shi, Zhong-Wei Zhao, Dong Yin, Da-Wei |
| author_sort | Li, Xiao-Ying |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7249706 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Wolters Kluwer Health |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72497062020-06-15 2019 Chinese expert consensus statement on aspirin application in primary prevention of cardiovascular disease Li, Xiao-Ying Shi, Zhong-Wei Zhao, Dong Yin, Da-Wei Chin Med J (Engl) Consensus Statement Wolters Kluwer Health 2020-05-20 2020-04-21 /pmc/articles/PMC7249706/ /pubmed/32433054 http://dx.doi.org/10.1097/CM9.0000000000000762 Text en Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
| spellingShingle | Consensus Statement Li, Xiao-Ying Shi, Zhong-Wei Zhao, Dong Yin, Da-Wei 2019 Chinese expert consensus statement on aspirin application in primary prevention of cardiovascular disease |
| title | 2019 Chinese expert consensus statement on aspirin application in primary prevention of cardiovascular disease |
| title_full | 2019 Chinese expert consensus statement on aspirin application in primary prevention of cardiovascular disease |
| title_fullStr | 2019 Chinese expert consensus statement on aspirin application in primary prevention of cardiovascular disease |
| title_full_unstemmed | 2019 Chinese expert consensus statement on aspirin application in primary prevention of cardiovascular disease |
| title_short | 2019 Chinese expert consensus statement on aspirin application in primary prevention of cardiovascular disease |
| title_sort | 2019 chinese expert consensus statement on aspirin application in primary prevention of cardiovascular disease |
| topic | Consensus Statement |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249706/ https://www.ncbi.nlm.nih.gov/pubmed/32433054 http://dx.doi.org/10.1097/CM9.0000000000000762 |
| work_keys_str_mv | AT lixiaoying 2019chineseexpertconsensusstatementonaspirinapplicationinprimarypreventionofcardiovasculardisease AT shizhongwei 2019chineseexpertconsensusstatementonaspirinapplicationinprimarypreventionofcardiovasculardisease AT zhaodong 2019chineseexpertconsensusstatementonaspirinapplicationinprimarypreventionofcardiovasculardisease AT yindawei 2019chineseexpertconsensusstatementonaspirinapplicationinprimarypreventionofcardiovasculardisease |